Palupiprant | m-entrepreneurship.com

Product Name :
Palupiprant

Search keywords :
Palupiprant

drugId :
null

Target Vo:
Prostanoid EP4 receptor

Target Vo Short Name :
PTGER4

Moa_Name:
Prostanoid EP4 receptor antagonists

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Eisai Co Ltd

Active Company_Name :
Adlai Nortye Ltd

Active Indication_Name:
Rectal Neoplasms

In Active Indication_Name:
Neoplasms

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:
Phase 1 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
alpha Tubulin Antibody
PKA 2 beta (regulatory subunit)Antibody
MCM2 Antibody (YA705): MCM2 Antibody (YA705) is a non-conjugated and Mouse origined monoclonal antibody about 102 kDa, targeting to MCM2 (2B5). It can be used for WB,IHC-F,IHC-P,ICC/IF,FC,IP assays with tag free, in the background of Human, Mouse.

Author: Betaine hydrochloride

Related Posts